​

AdaptHealth (AHCO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AHCO Stock Forecast

AdaptHealth (AHCO) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $13.00, with a high of $14.00 and a low of $12.00. This represents a 22.30% increase from the last price of $10.63.

$7 $8 $9 $10 $11 $12 $13 $14 High: $14 Avg: $13 Low: $12 Last Closed Price: $10.63

AHCO Stock Rating

AdaptHealth stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

AHCO Forecast vs Benchmarks

TypeNameUpside
StockAdaptHealth22.30%
SectorHealthcare Stocks 25.20%
IndustryMedical Device Stocks6.39%

Price Target Trends

1M3M12M
# Anlaysts-24
Avg Price Target-$13.00$13.75
Last Closing Price$10.63$10.63$10.63
Upside/Downside-22.30%29.35%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25153--9
Dec, 24153--9
Nov, 24253--10
Oct, 242531-11
Sep, 242531-11
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 15, 2024David MacDonaldTruist Financial$12.00$9.8022.45%12.89%
Nov 06, 2024Eric ColdwellRobert W. Baird$14.00$9.0754.36%31.70%
Sep 23, 2024Eric ColdwellRobert W. Baird$16.00$11.4240.11%50.52%
Aug 08, 2024Kevin CaliendoUBS$13.00$9.5336.41%22.30%
Sep 20, 2022Deutsche Bank$28.00$21.8128.38%163.41%
Sep 19, 2022Truist Financial$28.00$20.9833.46%163.41%
Aug 10, 2022RBC Capital$29.00$22.2430.40%172.81%
Aug 10, 2022Leerink Partners$29.00$22.2430.40%172.81%
Jul 26, 2022David MacDonaldTruist Financial$24.00$21.0014.29%125.78%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Aug 08, 2024UBSBuyBuyhold
May 15, 2024UBSBuyBuyhold
Mar 04, 2024UBSBuyBuyhold
Sep 20, 2022Deutsche BankBuyBuyhold
Sep 19, 2022SusquehannaBuyBuyhold
Aug 10, 2022RBC CapitalOutperformOutperformhold
Aug 10, 2022SVB LeerinkOutperformOutperformhold
Feb 18, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.12$1.12$0.52$-5.05-----
Avg Forecast$0.58$1.17$0.86$0.80$0.92$1.00$1.19$1.39$1.64
High Forecast$0.57$1.16$0.85$-0.26$0.89$0.96$0.80$1.36$1.61
Low Forecast$0.58$1.19$0.89$1.20$0.96$1.07$1.59$1.44$1.70
Surprise %-293.10%-4.27%-39.53%-731.25%-----

Revenue Forecast

$1B $2B $3B $4B $5B $7B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.06B$2.45B$2.97B$3.20B-----
Avg Forecast$1.03B$2.44B$2.98B$3.17B$3.23B$3.33B$3.51B$5.43B$6.20B
High Forecast$1.02B$2.41B$2.94B$3.16B$3.22B$3.28B$3.51B$5.35B$6.11B
Low Forecast$1.04B$2.46B$3.04B$3.25B$3.24B$3.42B$3.51B$5.58B$6.37B
Surprise %2.46%0.62%-0.26%1.04%-----

Net Income Forecast

$-1B $-700M $-400M $-100M $200M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-58.72M$156.18M$69.32M$-678.89M-----
Avg Forecast$77.77M$266.42M$194.60M$-678.89M$124.32M$136.45M$144.71M$186.84M$220.45M
High Forecast$76.75M$210.03M$155.68M$-814.67M$119.81M$129.60M$107.26M$183.09M$216.01M
Low Forecast$78.63M$322.81M$233.52M$-543.12M$128.82M$143.30M$213.18M$193.51M$228.32M
Surprise %-175.50%-41.38%-64.38%------

AHCO Forecast FAQ

Is AdaptHealth stock a buy?

AdaptHealth stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AdaptHealth is a favorable investment for most analysts.

What is AdaptHealth's price target?

AdaptHealth's price target, set by 4 Wall Street analysts, averages $13 over the next 12 months. The price target range spans from $12 at the low end to $14 at the high end, suggesting a potential 22.30% change from the previous close price of $10.63.

How does AdaptHealth stock forecast compare to the average forecast of its sector, industry, and investment themes?

AdaptHealth stock forecast shows a 22.30% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the medical device stocks industry (6.39%).

What is the breakdown of analyst ratings for AdaptHealth over the past three months?

  • January 2025: 11.11% Strong Buy, 55.56% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 11.11% Strong Buy, 55.56% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 20.00% Strong Buy, 50.00% Buy, 30.00% Hold, 0% Sell, 0% Strong Sell.

What is AdaptHealth’s EPS forecast?

AdaptHealth's average annual EPS forecast for its fiscal year ending in December is 0.92 for 2024, a -118.22% decrease from the reported $-5.05 in 2023. The prediction for 2025 is $1, $1.19 for 2026, $1.39 for 2027, and $1.64 for 2028.

What is AdaptHealth’s revenue forecast?

AdaptHealth's average annual revenue forecast for its fiscal year ending in December is $3.23B for 2024, a 1.04% increase from the reported $3.2B in 2023. The forecast for 2025 is $3.33B, $3.51B for 2026, $5.43B for 2027, and $6.2B for 2028.

What is AdaptHealth’s net income forecast?

For its fiscal year ending in December, AdaptHealth's average annual net income forecast is $124.32M for 2024, reflecting a -118.31% decrease from the reported $-679M in 2023. The projection for 2025 is $136.45M, $144.71M for 2026, $186.84M for 2027, and $220.45M for 2028.